A Cost-Benefit Analysis of Regulation on Securities Markets

被引：0
|
作者：
Zhe, Li [1 ]
机构：
[1] Wuhan Univ, Sch Econ & Management, Wuhan 430072, Peoples R China
来源：
PROCEEDINGS OF THE 15TH INTERNATIONAL CONFERENCE ON INDUSTRIAL ENGINEERING AND ENGINEERING MANAGEMENT, VOLS A-C | 2008年
关键词：
Regulation; A Cost-Benefit Analysis; Securities Markets;
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
Regulation on the securities market has to be examined on the basis of costs and benefits. Through a cost benefit analysis, not all the regulations on the securities market are worthy of carrying out. Through expounding the costs and the benefits of regulation on the securities market, this paper analyzes the vital of regulation by government and also suggests it might be too difficult to clarify all the costs and benefits of regulation on the securities market. Four levels of evaluating this regulation are followed to illustrate the measurement of this abstract problem. The pattern concerned and concrete examples are also presented.
引用
收藏
页码：2386 / 2388
页数：3
相关论文
共 50 条
  • [1] New foundations of cost-benefit analysis
    Adler, Matthew
    Posner, Eric A.
    REGULATION & GOVERNANCE, 2009, 3 (01) : 72 - 83
  • [2] Quadratic voting as an input to cost-benefit analysis
    Jonathan S. Masur
    Public Choice, 2017, 172 : 177 - 193
  • [3] Quadratic voting as an input to cost-benefit analysis
    Masur, Jonathan S.
    PUBLIC CHOICE, 2017, 172 (1-2) : 177 - 193
  • [4] Cost-benefit analysis: Regulatory reform or favoring the regulated?
    Hemphill T.
    Business Economics, 2007, 42 (1) : 61 - 65
  • [5] Cost-benefit analysis: New foundations on shifting sand
    Sinden, Amy
    Kysar, Douglas A.
    Driesen, David M.
    REGULATION & GOVERNANCE, 2009, 3 (01) : 48 - 71
  • [6] Tobacco Regulation and Cost-Benefit Analysis: How Should We Value Foregone Consumer Surplus?
    Levy, Helen G.
    Norton, Edward C.
    Smith, Jeffrey A.
    AMERICAN JOURNAL OF HEALTH ECONOMICS, 2018, 4 (01) : 1 - 25
  • [7] Cost-benefit analysis of the FDA: The case of the prescription drug user fee acts
    Philipson, Tomas
    Berndt, Ernst R.
    Gottschalk, Adrian H. B.
    Sun, Eric
    JOURNAL OF PUBLIC ECONOMICS, 2008, 92 (5-6) : 1306 - 1325
  • [8] Financial industry mobilisation and securities markets regulation in Europe
    Chalmers, Adam William
    EUROPEAN JOURNAL OF POLITICAL RESEARCH, 2015, 54 (03) : 482 - 501
  • [9] Implementation of Dynamic Tariffs in the Portuguese Electricity System - Preliminary Results of a Cost-Benefit Analysis
    Saraiva, J. T.
    Fidalgo, J. N.
    Pinto, R. B.
    Soares, R.
    Santos Afonso, J.
    Pires, G.
    2016 13TH INTERNATIONAL CONFERENCE ON THE EUROPEAN ENERGY MARKET (EEM), 2016,
  • [10] Mandatory clawback provisions, information disclosure, and the regulation of securities markets
    Denis, Diane K.
    JOURNAL OF ACCOUNTING & ECONOMICS, 2012, 54 (2-3): : 197 - 200
12345